Updates from the EURO-SKI trial of tyrosine kinase cessation
3 Dec 2016
Updates from the EURO-SKI trial of tyrosine kinase cessation
Incidence and risk factors for central venous catheter related thrombosis in children
CML patients with stable response may safely decrease dose of TKI
Vadastuximab talirine in combination for newly diagnosed AML
Novel antibody boosts responses in newly diagnosed AML
Anti CD22 CAR T cell therapy for relapsed paediatric ALL
A new spin on leukaemia therapy
Subgroup analysis of elderly high risk AML patients receiving CPX-351
Remissions following anti-CD22 CAR therapy in children with relapsed ALL
CPX-351 after stem cell transplant for elderly patients with AML
Skull base surgery
Advanced oral cancer in St Petersburg